Actively Recruiting
A Real-world Study on the Influencing Factors of Efficacy of Ruxolitinib Cream in Vitiligo
Led by Peking University Third Hospital · Updated on 2026-01-02
170
Participants Needed
1
Research Sites
107 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Vitiligo is a common chronic autoimmune skin disease that can occur on any part of the body and severely impacts patients' quality of life. Current treatment for vitiligo primarily include topical medications, phototherapy, systemic therapy and surgical interventions, but their efficacy is limited, often failing to achieve ideal therapeutic outcomes, and are associated with a high recurrence rate. This study is an investigator-initiated real-world research on the application of ruxolitinib cream for vitiligo treatment, with the primary objective of exploring the factors influencing the efficacy of ruxolitinib cream in treating vitiligo.
CONDITIONS
Official Title
A Real-world Study on the Influencing Factors of Efficacy of Ruxolitinib Cream in Vitiligo
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 12 years or older, any gender
- Signed informed consent form
- Clinically diagnosed with non-segmental vitiligo
- Vitiligo area less than 10% of body surface area
- Agreed to stop all other vitiligo treatments from screening until final follow-up
- Female participants must not plan pregnancy or oocyte donation from screening until 4 weeks after last dose and must use effective physical contraception
- Male participants must not plan fertility or sperm donation during the same period and must use effective physical contraception, including barrier methods, intrauterine devices/systems, surgical sterilization performed at least 6 months prior, or other investigator-approved methods
You will not qualify if you...
- Allergy to ruxolitinib cream
- Pregnant or lactating women
- Any condition the investigator considers unsuitable for study participation
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Peking University Third Hospital
Beijing, China, 100191
Actively Recruiting
Research Team
J
Jinzhu Guo, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here